THE Cann Group has more than doubled personnel at its Mildura medicinal cannabis production facility since the beginning of 2022 as sales revenue nears $10 million for the nine months to March this year.

The company reported sales revenue for the third quarter of 2022-23 of $4.05 million, representing a 219 per cent increase on the previous corresponding period.